In vivo modulation of vincristine-induced neurotoxicity in Lymnaea stagnalis, by the ACTH(4-9) analogue Org 2766

Journal of Neuro-Oncology

Volumn 30, Issue 3, 1996, Pages 173-180

  Kiburg, Barbara ^a,b   Moorer van Delft, Carry M ^a   Hermans, Jan J ^b   Huijgens, Peter C ^b   Boer, Harry H ^a  

^a VU UNIVERSITY MEDICAL CENTER   (Netherlands)

^b VU UNIVERSITY AMSTERDAM   (Netherlands)

Author keywords

Lymnaea stagnalis; Microtubules; Neurotoxicity; Org 2766; Vincristine

Indexed keywords

2 AMINO 4 (METHYLSULFONYL)BUTYRYLGLUTAMYLHISTIDYLPHENYLALANYL DEXTRO LYSYLPHENYLALANINE; CORTICOTROPIN DERIVATIVE; VINCRISTINE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; ELECTRON MICROSCOPY; MICROTUBULE; NEUROTOXICITY; NONHUMAN; PERIPHERAL NEUROPATHY; SNAIL;

ADRENOCORTICOTROPIC HORMONE; ANIMALS; ANTICONVULSANTS; ANTINEOPLASTIC AGENTS, PHYTOGENIC; AXONS; CRYSTALLIZATION; GANGLIA, INVERTEBRATE; LYMNAEA; MICROSCOPY, ELECTRON; MICROTUBULES; NEURONS; NEUROTOXINS; PEPTIDE FRAGMENTS; VINCRISTINE;

EID: 0029860532     PISSN: 0167594X     EISSN: None     Source Type: Journal    
DOI: 10.1007/BF00177268     Document Type: Article

References (31)

1. Bender RA, Chabner BA: Tubulin binding agents. In; Chabner B (ed) Pharmacologic principles of cancer treatment. Saunders WB Company, Philadelphia, 1982, pp 256-262
2. Dustin P; Structure and Chemistry of Microtubules. In: Dustin P (ed) Microtubules. Springer-Verlag, Berlin, Heidelberg, New York, 1978, pp 23-70
3. Bunt AH: Paracrystalline inclusions in optic nerve terminals following intraocular injection of vinblastine. Brain Res 53: 29-39, 1973
4. Donoso JA, Green LS, Heller-Bettinger IE, Samson FE: Action of the vinca alkaloids vincristine, vinblastine and desacetyl vinblastine amide on axonal fibrillar organelles in vitro. Cancer Res 37:1401-1407, 1977
5. Green LS, Donoso JA, Heller-Bettinger IE, Samson FE: Axonal transport disturbances in vincristine-induced peripheral neuropathy. Ann Neurol 1: 255-262, 1977
6. Müller LJ, Moorer-van Delft CM, Zijl R, Doubos EW: Use of snail neurons in developing quantitative ultrastructural parameters for neurotoxic side effects of vinca antitumor agents. Cancer Res 50:1924-1928, 1990
7. Schochet SS, Lampert PW, Earle KM: Neuronal changes induced by intrathecal vincristine sulfate. J Neuropathol Exp Neurol 27: 645-658, 1968
8. Sandier SG, Tobin W, Henderson ES: Vincristine-induced neuropathy. Neurology 19: 367-374, 1969
9. Legha SS: Vincristine neurotoxicity - pathophysiology and management. Med Toxicol 1: 421-427, 1986
10. Jackson DV, McMahan RA, Pope EK, Case LD, Cooper MR, Kaplon MK, Richards F, Stuart JJ, White DR, Zekan PJ: Clinical trial of folinic acid to reduce vincristine neurotoxicity. Cancer Chemother Pharmacol 17: 281-284, 1986
11. Jackson DV, Pope EK, McMahan RA, Cooper MR, Atkins JN, Callahan RD, Paschold EH, Grimm RA, Hopkins JO, Muss HB, Richards F, Stuart JJ, White DR, Zekan PJ, Cruz JM, Spurr CL, Capizzi RL: Clinical trial of pyridoxine to reduce vincristine neurotoxicity. J Neuro-Oncol 4:37-41, 1986
12. Jackson DV, Wells HB, Atkins JN, Zekan PJ, White DR, Richards II F, Cruz JM, Muss HB: Amelioration of vincristine neurotoxicity by glutamic acid. Am J Med 84: 1016-1022, 1988
13. Koning P de, Neijt JP, Jennekens FGI, Gispen WH: ORG 2766 protects from cisplatin-induced neurotoxicity in rats. Exp Neurol 97:746-750,1987
14. Gerritsen van der Hoop R, Koning P de, Boven E, Neijt JP, Jennekens FG, Gispen WH: Efficacy of the neuropeptide ORG 2766 in the prevention and treatment of cisplatin-induced neurotoxicity in rats. Eur J Cancer Clin Oncol 24: 637-642, 1988
15. (4-9) analogue in patients with ovarian cancer. N Engl J Med 322: 89-94, 1990
16. Kooten B van, Diemen van HAM, Groenhout KM, Huijgens PC, Ossenkoppele GJ, Nauta JJP, Heimans JJ: A pilot study on the influence of a corticotrophin (4-9) analogue on vinca alkaloid-induced neuropathy. Arch Neurol 49: 1027-1031, 1992
17. (4-9) analogue, ORG 2766, on vincristine cytotoxicity in two human lymphoma cell lines, U 937 and U 715. Br J Cancer 69: 497-501, 1994
18. Koning P de, Gispen WH: ORG 2766 improves functional and electrophysiological aspects of regenerating sciatic nerve in the rat. Peptides 8: 415-422, 1987
19. Gerritsen van der Hoop R, Brakkee JH, Kapelle A, Samson M, Koning P de, Gispen WH: A new approach for the evaluation of recovery after peripheral nerve damage. J Neurosci Methods 26:111-116, 1988
20. (4-9) analogue ORG 2766 stimulates microtubule formation in axons of central neurons of the snail Lymnaea stagnate. Peptides 13: 769-774, 1992
21. (4-9) analogue, op peptidergic neurons and glial cells in the snail Lymnaea stagnalis. Peptides 15 (1): 143-149, 1994
22. (4-9) analogue, modulates vincristine-induced neurotoxicity in the snail Lymnaea stagnalis. Int J Oncol 5: 647-653, 1994
23. Rosenthal S, Kaufman S: Vincristine neurotoxicity. Ann Int Med 80: 733-737, 1974
24. Postma TJ, Benard BA, Huijgens PC, Ossenkoppele GJ, Heimans JJ: Long term effects of vincristine on the peripheral nervous system. J Neuro-Oncol 15: 23-27, 1993
25. (4-9) analogue, in neuroblastoma cells. Ann New York Acad Sci 679: 270-275, 1993
26. Windebank AJ, Smith AG, Russel JW: The effect of nerve growth factor, ciliary neurotrophic factor and ACTH analogs on cisplatin neurotoxicity in vitro. Neurology 44: 488494, 1994
27. Müller LJ, Moorer-van Delft CM, Roubos EW, Boer HH: Neurons of the snail Lymnaea stagnalis as a model to study the neurotoxic side-effects of cytostatic compounds and the protective properties of ORG 2766, an ACTH-analogue. In: Kits KS, Boer HH, Joosse J (eds) Molluscan Neurobiology. Elsevier North Holland Publ Comp, Amsterdam, Oxford, New York, 1991, pp 227-234
28. Strand FL, Rose KJ, Zuccarelli LA, Kume J, Alves SE, Antonawich FJ, Garrett LY: Neuropeptide hormones as neurotrophic factors. Phys Rev 71 (4): 1017-1046, 1991
29. Takanari H, Yosida T, Morita J, Izutsu K, Ito T: Instability of pleomorphic tubulin paracrystals artificially induced by vinca alkaloids in tissue-cultured cells. Biol Cell 70:83-90, 1990
30. Casey EB, Jellife AM, Le Quesne PM, Millett YL: Vincristine neuropathy - Clinical and electrophysiological observations. Brain 96: 69-86, 1973
31. 3H]-vincristine in man. Clin Pharmacol Ther 22 (4): 430-438, 1977